Economic Navigation and Strengthening to Research Unrestricted Services for Transgender Women (ENTRUST)
Recruiting · NCT06202898 · Interventional (participants receive a specific treatment) · Lead sponsor: University of Central Florida
View the official record on ClinicalTrials.gov →Interventions studied
BaselineControlENTRUST
What this trial is about
The overall hypothesis is that stabilizing transgender women financially while providing them tailored counselling will increase their odds of them linking to substance use services, PrEP services if they do not have HIV, and transgender women who are living with HIV will be more adherent to their ART treatment.
Who can take part
Age range
18 Years and older
Sex
Male
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Aged ≥18 years
- Male at birth
- Identify as a woman/transgender woman
- Should not be consistently using PrEP (less than four doses per week)
- Should not have any known allergy or adverse reaction to PrEP or the active drug tenofovir in ART. One of the goals of the study is to move more people into a PrEP program
- Be able to speak and understand spoken English and/or Spanish (including persons who cannot read or write)
- Have a smart phone that can take pictures
Exclusion criteria
- Unwilling to adhere to study procedures
- Participation in an HIV vaccine trial
- Have a life-threatening SUD\*
- Any condition, that in the opinion of the study staff, would make participation in the study unsafe, or interfere with achieving the study objective such as medical conditions which prevents the use of PrEP
- Unable to provide consent
Where it is running
1 location listed across 1 US state.
- University of Central Florida - Orlando, Florida, United States